Mr Hamish Cameron

KANDO id: 34642

Bio

Joined SVLS in 2008 as a Venture Partner. Before joining SVLS, was CEO of Cambridge Antibody Technology (“CAT”). Prior to that, held a series of senior R&D positions at AstraZeneca/Zeneca including Head of the Cardiovascular Therapy Area, Senior Vice-President Medical Research and was a member of the R&D Leadership Team. Started his industry career with Janssen, after working in clinical practice and research in the UK. Trained as a physician and holds MBBS and BSc (Hons) Pharmacology degrees from the University of London. Member of the UK Royal College of Physicians and a Fellow and past Board member of the Faculty of Pharmaceutical Medicine.

Education